Friday, 5 May 2017

Johnson & Johnson ordered to pay $110m in US talc cancer case




Pharmaceutical firm Johnson & Johnson (J&J) has been ordered by a US court to pay more than $110m (£85m) to a woman who says she developed ovarian cancer after using its talcum powder.

 
Lois Slemp, 62, from Virginia, Missouri said she developed the cancer after four decades of using talc products.


Prosecutors argued the company did not adequately warn about the cancer risks associated with the items.


Experts say links with ovarian cancer are unproven. J&J says it will appeal.


The verdict in a St Louis state court is the largest so far to arise out of about 2,400 lawsuits against J&J over its talc-based products, Reuters news agency reports.
Ms Slemp is currently undergoing chemotherapy after her ovarian cancer initially diagnosed in 2012 returned and spread to her liver.


She said the products she used included J&J's Baby Powder and Shower to Shower Powder.


"Once again we've shown that these companies ignored the scientific evidence and continue to deny their responsibilities to the women of America," said Ted Meadows, a lawyer for Ms Slemp.


The verdict included $5.4m in compensatory damages and $105m in punitive damages against J&J.


The company said it planned to appeal. "We are preparing for additional trials this year and we continue to defend the safety of Johnson's Baby Powder," it said in a statement.


"We deeply sympathise with the women and families impacted by ovarian cancer."




BBC      News.